|
Market Data
Teleflex Incorporated
Teleflex Incorporated is a global medical device manufacturer specializing in single-use products designed for a broad range of diagnostic and therapeutic procedures. The company's core value proposition lies in its diverse portfolio, encompassing vascular access, interventional, anesthesia, surgical, urology, and respiratory products, catering to critical care and surgical applications. Teleflex's offerings, including the Arrow brand and the UroLift System, are utilized in hospitals, healthcare settings, and home care environments. Its competitive advantage is derived from a wide product range and a focus on providing solutions for a variety of medical needs. Established in 1943, Teleflex continues to serve healthcare providers worldwide from its headquarters in Wayne, Pennsylvania.
TFX is currently trading at $131.79, giving Teleflex Incorporated a market cap of 5.82B. Today's range spans $128.60–$134.81, with shares opening at $132.50 and moving up $0.21 (0.2%) from the prior close. DailyIQ's technical score sits at 86/100 (BUY) with a news sentiment reading of 59/100.
Over the past year TFX has traded between $100.18 and $138.93 - the current price is +31.6% off the 52-week low and -5.1% from the high. 18 analysts cover the stock with a Hold consensus and a mean 12-month target of $132.78 (range $115.00–$147.00), implying upside of +0.8%.
The data on Teleflex Incorporated (TFX) makes a clear case: BUY signal, 86/100 technical score, neutral sentiment at 59/100, price $131.79 (in the upper portion of its 52-week range). At 5.82B in Healthcare market cap, this is a name where the traditional risk/reward calculus shifts - lower liquidity means wider spreads and faster moves, but the bullish setup with sentiment confirmation reduces the probability of a failed breakout. Annual range: $100.18–$138.93.
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'26 | $1.22 | - | - |
| Q4'25 | $3.77 | $1.93 | -48.8% |
| Q3'25 | $3.38 | $3.67 | +8.6% |
| Q2'25 | $3.37 | $3.73 | +10.8% |
| Q1'25 | $2.88 | $2.91 | +0.9% |
| Q4'24 | $3.88 | $3.89 | +0.4% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'26 | $538M | - | - |
| Q4'25 | $928M | $569M | -38.7% |
| Q3'25 | - | $893M | - |
| Q2'25 | - | $781M | - |
| Q1'25 | - | $701M | - |
| Q4'24 | - | $795M | - |
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).